Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus: Systematic review and meta-analysis of cardiovascular outcomes trials

Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, Kyungah Im, Erica L. Goodrich, Remo H.M. Furtado, Marc P. Bonaca, Ofri Mosenzon, Eri T. Kato, Avivit Cahn, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Marc S. Sabatine

Research output: Contribution to journal › Article › peer-review

509 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus: Systematic review and meta-analysis of cardiovascular outcomes trials'. Together they form a unique fingerprint.

Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus: Systematic review and meta-analysis of cardiovascular outcomes trials

Fingerprint

Medicine & Life Sciences